Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone for Clozapine-Induced Glucose Metabolism Impairment
NCT00337350Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2003
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in glucose metabolism disorder, sponsored by Massachusetts General Hospital. Started Sep 2003; status: completed.
02
Drugs
rosiglitazone
03
Conditions
glucose metabolism disorder
Beyond the preview
Go deeper on NCT00337350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337350.